The Question of Finding an MD to Work With You on Ivermectin for Cancer

Executive Summary

• People often ask about a referral to an MD who will help them treat cancer with Ivermectin.
• This article covers why this is a rarity.

Introduction

We commonly receive a question through our chat widget asking if we can recommend an MD who will work with the questioner treating an ailment with Ivermectin. This question misses how medicine, hospitals, and treatment centers work.

How MDs Will Typically Work With Ivermectin

MDs don’t work with Ivermectin except as an antiparasitic. This is because Ivermectin is not part of the business model for the medical establishment to use Ivermectin for the benefits most people like to use it for.

One area for which Ivermectin is used outside of the medical establishment is cancer.

MD Anderson did not grow to become a $10.6 billion per year business by administering inexpensive but effective drugs like Ivermectin. Do you think that MD Anderson or any other cancer hospital is in the business of reducing its revenues? 

Considering the Business Model of MDs and Cancer Centers/Hospitals

Imagine for a minute you were running a cancer center. And you are recommending chemo drugs to patients. I cover the effectiveness of chemotherapy section of the Cancer Articles. However, most people who contract cancer do not know the effectiveness of chemotherapy or other treatments their doctors recommend. That was one of the original reasons for this site – to compare the recommended treatments by the medical establishment to the research into their effectiveness. However, this niche site will only ever provide exposure to a minimal number of patients.

This means the medical establishment can push whatever treatment proposal they want, and most patients will follow their doctors’ advice. Therefore, there is little pushback on ineffective treatments by the public.

Examples of the Medical Establishment’s Coverage of Ivermetin for Covid

The medical establishment demonstrated clearly how little it cares about treatment effectiveness with its coverage of Ivermectin for covid.

This is the typical view that MDs have of Ivermectin. Most MDs are never trained to think critically and know they can maximize their income and status by simply following the medical establishment’s status quo- profit maximizing for pharmaceutical companies, hospitals, etc. 

Review the video above — which is by ABC News, which receives enormous amounts of pharmaceutical manufacturing — which is not disclosed. 

Now compare that last video to the following comparison of Ivermectin at C19Early.com, which compiles studies.

Notice that Ivermectin has many more studies than the drugs above it in effectiveness. Those drugs were funded by pharmaceutical companies and are guaranteed to be exaggerated in effectiveness. With more studies, those items will drop far below the efficacy of Ivermectin. 

Putting Yourself in the Position of an MD or a Person Running a Cancer Center or Hospital

The idea that hospitals can be non-profits is quite misleading. Hospitals use their non-profit status to exempt themselves from taxation, but then they are run, at least in the US, as completely profit-maximizing entities. This is a holdover from when hospitals had a public service function, such as when church organizations ran them and charged very little for their services. Now, they charge at bankrupting levels but have maintained their tax-free status.

The hospitals want to make the best possible money, and the MDs wish to make the money they can. Making a large amount of money is mostly why MDs become MDs. Cancer treatments like chemotherapy can be in the multiple $100,000 per year. New immunotherapies are even higher.

Every year, cancer treatments get more expensive. That is the market MDs prefer being in. Cancer treatment and cancer research is a great business. As we joke, it is much more beneficial for those who administer chemotherapy than those who have to receive chemotherapy.

The Reality: Ivermectin is Not a Profitable Treatment for Cancer Centers

When a cancer center is looking to administer a treatment, they are looking for hundreds of thousands of dollars annually. Try to find a conventional cancer treatment that costs less than this. Ivermectin is not profitable enough to interest the medical establishment. Furthermore, Ivermectin undermines very profitable lines of business.

As a business, they can’t do this, and businesses do not jeopardize their revenue streams. The reality is that treating cancer effectively is not particularly expensive.

This happens when any medical system, based on advising customers or patients on what treatments they should use, places profits above everything else.

The Tactics of Medicine to Diminish Less Expensive Options

Lower-cost but effective treatments are diminished, and the most expensive options become standardized as the treatment of choice by the medical establishment. Look at the increase in the price of so many generic drugs that has occurred. Many of these drugs have been out for decades. However, the drugs have been increased in price by hundreds or even thousands of percent.

• What costs are these price increases required to cover?
• Why is the average new cancer drug now that is approved by the FDA over $250,000?
• The US does not have price caps on drugs, and therefore, the price is whatever the drug companies can get away with charging.

There is ample evidence that Ivermectin is effective against many different ailments. However, it is not sufficiently profitable for MDs to want to participate in prescribing it. Furthermore, MDs that do so are considered to be crossing a line. If an MD prescribes Zoloft for PMDD (in this example, Zoloft for PMDD is off-label), which means the FDA does not approve the use, the medical establishment welcomes this. However, suppose the same MD prescribes Ivermectin for cancer, which would be an off-label prescription. In that case, this is because Ivermectin is not approved for treating cancer even though there is ample evidence for the effectiveness of Ivermectin against cancer, which we cover at this site.

This second scenario is a problem for that MD. This is because the medical establishment orients off-label prescribing in a profit-maximizing way to the pharmaceutical companies and the medical establishment overall.

The Potential Ramifications for MDs Prescribing Ivermectin as Well as Other Integrative Cancer Treatments

The following quote is from the article Integrative Approaches For Cancer.

That’s because it’s been well known for decades within the integrative medical field that the fastest way to lose your medical license is to practice unapproved cancer therapies and over the decades, countless examples have been made of doctors who did so.

In turn, most of the doctors I know who utilize integrative cancer therapies (and have success in treating cancer) only offer this service to longtime patients they have a very close relationship with and explicitly request for me to not send patients to them.

This quote is from the New York Times, Pennsylvania, Doctor Accused of Prescribing Ivermectin for Covid Is Fired. It describes what happened to one MD who broke with the medical authorities and was prescribed Ivermectin.

A Pennsylvania doctor accused of prescribing ivermectin and hydroxychloroquine to treat Covid-19, two drugs that regulators have called not safe for treating the disease, was fired this week, a regional health system said.

The doctor, Edith Behr, who worked for Tower Health, was accused of writing prescriptions for the drugs, which are not approved for the prevention or treatment of Covid, the company said. The health system said it became aware of the allegations against Dr. Behr on Wednesday.

If you were an MD, would you want to risk something like this? The fact that you could prove that Ivermectin is one of the best drugs for Ivermectin will not stop the medical establishment from retaliating against you.

This is an important video explaining what happens to MDs who diverge from the approved treatments and approved thinking regarding how medical boards can punish them. In most cases, these boards are highly controlled by pharmaceutical companies, and in the case of Jordan Peterson, his Canadian psychology board enforced politically correct restrictions on his speech. 

Conclusion

• There are exceptions, but MDs that do work with Ivermectin for things other than as an antiparasitic or skin condition like rosacea are few and far between, and they keep their prescribing secret.
• One cannot expect MDs to work with Ivermectin when they risk so much doing so, combined with the fact that Ivermectin is counter to their financial incentives and the incentives of the institutions they work for.

The good news is that you don’t need an MD to help with being prescribed Ivermectin.

Regarding information, we have more research at this site related to all the important aspects of Ivermectin than any MD will have –, and this is mostly secondary research — which means we base our articles on published studies that demonstrate Ivermectin’s effectiveness. And we have much more, with Ivermectin covered from many dimensions. This means you can learn everything you need from this site.

Finally, trying to engage with MDs on Ivermectin is an uphill battle. First, you are jeopardizing them by getting them to work with you on Ivermectin. This is because all the medical authorities oppose using Ivermectin for anything but as an antiparasitic or for rosacea. Off-label prescribing is only allowed for drugs the medical establishment favors. Remember, this has nothing to do with proven effectiveness; it is medical politics. It’s not a realistic expectation to expect them to put themselves at professional risk to improve your health.

Their orientation and control they are under is explained in the quote from the article What Happens to Doctors Who Innovate?

Doctors are always in fear of losing their medical license (as there are a lot of technicalities a medical board can chose to target a doctor’s license with). In turn, the threat of industry sponsored medical boards has been one of the main things that has kept doctors from ever going too far out of the box (e.g., very few physicians I know will do integrative cancer treatments for this reason—and those that do so do as discretely as possible).

MDs should be used only for what they offer, not for things they are punished for offering.

Similarly, you don’t go to an MD and ask them questions about nutrition. The medical establishment opposes focusing on nutrition and prevention and they typically know little about either of these topics. MDs are paid to treat medical problems, not to prevent them from occurring in the first place.

We Are Presently Using Ivermectin Without Consulting an Oncologist

Everyone at Brightwork takes Ivermectin, as I cover in the article Does Everyone at Brightwork Take Ivermectin? Everyone here takes the dose from the dosage calculator at The Brightwork Ivermectin Dosage Guide article.

That dosage estimation is based on the many research papers on Ivermectin we reviewed. We have articles on the benefits of Ivermectin versus cancer and safety information on Ivermectin on this site.

None of us happen to have cancer, as we take Ivermectin as part of prevention and overall health improvement. Remember that Ivermectin is a cancer preventative and an overall immunomodulator beneficial for preventing cancer and many other ailments. What would an oncologist or any other MD add to the mix in taking Ivermectin? They are only familiar with the dosage for using Ivermectin as an antiparasitic. We would be wasting our time and frustrating MDs by engaging them on a topic in which they have little knowledge and little interest.

About Our Ivermecting Testing Program and Recommended Ivermectin Source of Supply

• We performed pharmaceutical testing on Ivermectin to find a lower-cost version that also matched Merck's original Ivermectin in bioequivalence.
• You can read about the details of our Ivermectin testing in this article, Our Ivermectin Bioequivalence Testing.
• We got Summit Products to carry this version of Ivermectin, which passed our bioequivalence testing.